Global Non-alcoholic Steatohepatitis (NASH) Market 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	154 Pages	TechNavio	August, 2024	INF19287798

Best Price Guarantee
Price	from $2,500
Length	154 Pages
Publisher	TechNavio
Published Date	August, 2024
SKU	INF19287798

Global Non-Alcoholic Steatohepatitis (Nash) Market 2024-2028

The non-alcoholic steatohepatitis (nash) market is forecasted to grow by USD 31461.3 mn during 2023-2028, accelerating at a CAGR of 58.37% during the forecast period. The report on the non-alcoholic steatohepatitis (nash) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of obesity and metabolic syndrome, rise in global aging population, and advancements in diagnostic technologies.

Technavio's non-alcoholic steatohepatitis (nash) market is segmented as below:

By Distribution Channel
Offline
Online
By Application
Diagnosis
Treatment
By Geographical Landscape
North America
Europe
Asia
Rest of World (ROW)

This study identifies the rising patient engagement and education as one of the prime reasons driving the non-alcoholic steatohepatitis (nash) market growth during the next few years. Also, emergence of combination therapies and integration of digital health solutions will lead to sizable demand in the market.

The report on the non-alcoholic steatohepatitis (nash) market covers the following areas:

Non-alcoholic steatohepatitis (nash) market sizing
Non-alcoholic steatohepatitis (nash) market forecast
Non-alcoholic steatohepatitis (nash) market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading non-alcoholic steatohepatitis (nash) market vendors that include AstraZeneca Plc, BioPredictive S.A.S, Cirius Therapeutics, Enzo Biochem Inc., GENFIT SA, Gilead Sciences Inc., GlaxoSmithKline Plc, Intercept Pharmaceuticals Inc., Inventiva S.A., Madrigal Pharmaceuticals Inc., Novo Nordisk AS, Prometheus Laboratories, Siemens Healthineers AG, and Zydus Lifesciences Ltd.. Also, the non-alcoholic steatohepatitis (nash) market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market By Geographical Landscape; Executive Summary - Chart on Market Segmentation by Distribution Channel; Executive Summary - Chart on Market Segmentation by Application; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 2.2 Market characteristics; Market characteristics analysis; 2.3 Value chain analysis; Value Chain Analysis
3 Market Sizing: 3.1 Market definition; Offerings of companies included in the market definition; 3.2 Market segment analysis; Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Chart on Global - Market size and forecast 2023-2028 ($ million); Data Table on Global - Market size and forecast 2023-2028 ($ million); Chart on Global Market: Year-over-year growth 2023-2028 (%); Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Global Non-Alcoholic Steatohepatitis (NASH) Market 2018 - 2022; Historic Market Size - Data Table on Global Non-Alcoholic Steatohepatitis (NASH) Market 2018 - 2022 ($ million); 4.2 Distribution Channel segment analysis 2018 - 2022; Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million); 4.3 Application segment analysis 2018 - 2022; Historic Market Size - Application Segment 2018 - 2022 ($ million); 4.4 Geography segment analysis 2018 - 2022; Historic Market Size - Geography Segment 2018 - 2022 ($ million); 4.5 Country segment analysis 2018 - 2022; Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis: 5.1 Five forces summary; Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Distribution Channel: 6.1 Market segments; Chart on Distribution Channel - Market share 2023-2028 (%); Data Table on Distribution Channel - Market share 2023-2028 (%); 6.2 Comparison by Distribution Channel; Chart on Comparison by Distribution Channel; Data Table on Comparison by Distribution Channel; 6.3 Offline - Market size and forecast 2023-2028; Chart on Offline - Market size and forecast 2023-2028 ($ million); Data Table on Offline - Market size and forecast 2023-2028 ($ million); Chart on Offline - Year-over-year growth 2023-2028 (%); Data Table on Offline - Year-over-year growth 2023-2028 (%); 6.4 Online - Market size and forecast 2023-2028; Chart on Online - Market size and forecast 2023-2028 ($ million); Data Table on Online - Market size and forecast 2023-2028 ($ million); Chart on Online - Year-over-year growth 2023-2028 (%); Data Table on Online - Year-over-year growth 2023-2028 (%); 6.5 Market opportunity by Distribution Channel; Market opportunity by Distribution Channel ($ million); Data Table on Market opportunity by Distribution Channel ($ million)
7 Market Segmentation by Application: 7.1 Market segments; Chart on Application - Market share 2023-2028 (%); Data Table on Application - Market share 2023-2028 (%); 7.2 Comparison by Application; Chart on Comparison by Application; Data Table on Comparison by Application; 7.3 Diagnosis - Market size and forecast 2023-2028; Chart on Diagnosis - Market size and forecast 2023-2028 ($ million); Data Table on Diagnosis - Market size and forecast 2023-2028 ($ million); Chart on Diagnosis - Year-over-year growth 2023-2028 (%); Data Table on Diagnosis - Year-over-year growth 2023-2028 (%); 7.4 Treatment - Market size and forecast 2023-2028; Chart on Treatment - Market size and forecast 2023-2028 ($ million); Data Table on Treatment - Market size and forecast 2023-2028 ($ million); Chart on Treatment - Year-over-year growth 2023-2028 (%); Data Table on Treatment - Year-over-year growth 2023-2028 (%); 7.5 Market opportunity by Application; Market opportunity by Application ($ million); Data Table on Market opportunity by Application ($ million)
8 Customer Landscape: 8.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Chart on Market share By Geographical Landscape 2023-2028 (%); Data Table on Market share By Geographical Landscape 2023-2028 (%); 9.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 9.3 North America - Market size and forecast 2023-2028; Chart on North America - Market size and forecast 2023-2028 ($ million); Data Table on North America - Market size and forecast 2023-2028 ($ million); Chart on North America - Year-over-year growth 2023-2028 (%); Data Table on North America - Year-over-year growth 2023-2028 (%); 9.4 Europe - Market size and forecast 2023-2028; Chart on Europe - Market size and forecast 2023-2028 ($ million); Data Table on Europe - Market size and forecast 2023-2028 ($ million); Chart on Europe - Year-over-year growth 2023-2028 (%); Data Table on Europe - Year-over-year growth 2023-2028 (%); 9.5 Asia - Market size and forecast 2023-2028; Chart on Asia - Market size and forecast 2023-2028 ($ million); Data Table on Asia - Market size and forecast 2023-2028 ($ million); Chart on Asia - Year-over-year growth 2023-2028 (%); Data Table on Asia - Year-over-year growth 2023-2028 (%); 9.6 Rest of World (ROW) - Market size and forecast 2023-2028; Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); 9.7 US - Market size and forecast 2023-2028; Chart on US - Market size and forecast 2023-2028 ($ million); Data Table on US - Market size and forecast 2023-2028 ($ million); Chart on US - Year-over-year growth 2023-2028 (%); Data Table on US - Year-over-year growth 2023-2028 (%); 9.8 Germany - Market size and forecast 2023-2028; Chart on Germany - Market size and forecast 2023-2028 ($ million); Data Table on Germany - Market size and forecast 2023-2028 ($ million); Chart on Germany - Year-over-year growth 2023-2028 (%); Data Table on Germany - Year-over-year growth 2023-2028 (%); 9.9 Canada - Market size and forecast 2023-2028; Chart on Canada - Market size and forecast 2023-2028 ($ million); Data Table on Canada - Market size and forecast 2023-2028 ($ million); Chart on Canada - Year-over-year growth 2023-2028 (%); Data Table on Canada - Year-over-year growth 2023-2028 (%); 9.10 China - Market size and forecast 2023-2028; Chart on China - Market size and forecast 2023-2028 ($ million); Data Table on China - Market size and forecast 2023-2028 ($ million); Chart on China - Year-over-year growth 2023-2028 (%); Data Table on China - Year-over-year growth 2023-2028 (%); 9.11 UK - Market size and forecast 2023-2028; Chart on UK - Market size and forecast 2023-2028 ($ million); Data Table on UK - Market size and forecast 2023-2028 ($ million); Chart on UK - Year-over-year growth 2023-2028 (%); Data Table on UK - Year-over-year growth 2023-2028 (%); 9.12 Market opportunity By Geographical Landscape; Market opportunity By Geographical Landscape ($ million); Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Opportunity/Restraints: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Impact of drivers and challenges in 2023 and 2028; 10.4 Market opportunities/restraints
11 Competitive Landscape: 11.1 Overview; 11.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 11.3 Landscape disruption; Overview on factors of disruption; 11.4 Industry risks; Impact of key risks on business
12 Competitive Analysis: 12.1 Companies profiled; Companies covered; 12.2 Market positioning of companies; Matrix on companies position and classification; 12.3 AstraZeneca Plc; AstraZeneca Plc - Overview; AstraZeneca Plc - Product / Service; AstraZeneca Plc - Key news; AstraZeneca Plc - Key offerings; 12.4 BioPredictive S.A.S; BioPredictive S.A.S - Overview; BioPredictive S.A.S - Product / Service; BioPredictive S.A.S - Key offerings; 12.5 Cirius Therapeutics; Cirius Therapeutics - Overview; Cirius Therapeutics - Product / Service; Cirius Therapeutics - Key offerings; 12.6 Enzo Biochem Inc.; Enzo Biochem Inc. - Overview; Enzo Biochem Inc. - Product / Service; Enzo Biochem Inc. - Key news; Enzo Biochem Inc. - Key offerings; 12.7 GENFIT SA; GENFIT SA - Overview; GENFIT SA - Product / Service; GENFIT SA - Key offerings; 12.8 Gilead Sciences Inc.; Gilead Sciences Inc. - Overview; Gilead Sciences Inc. - Product / Service; Gilead Sciences Inc. - Key news; Gilead Sciences Inc. - Key offerings; 12.9 GlaxoSmithKline Plc; GlaxoSmithKline Plc - Overview; GlaxoSmithKline Plc - Business segments; GlaxoSmithKline Plc - Key news; GlaxoSmithKline Plc - Key offerings; GlaxoSmithKline Plc - Segment focus; 12.10 Intercept Pharmaceuticals Inc.; Intercept Pharmaceuticals Inc. - Overview; Intercept Pharmaceuticals Inc. - Product / Service; Intercept Pharmaceuticals Inc. - Key offerings; 12.11 Inventiva S.A.; Inventiva S.A. - Overview; Inventiva S.A. - Product / Service; Inventiva S.A. - Key offerings; 12.12 Madrigal Pharmaceuticals Inc.; Madrigal Pharmaceuticals Inc. - Overview; Madrigal Pharmaceuticals Inc. - Product / Service; Madrigal Pharmaceuticals Inc. - Key offerings; 12.13 Novo Nordisk AS; Novo Nordisk AS - Overview; Novo Nordisk AS - Business segments; Novo Nordisk AS - Key offerings; Novo Nordisk AS - Segment focus; 12.14 Prometheus Laboratories; Prometheus Laboratories - Overview; Prometheus Laboratories - Product / Service; Prometheus Laboratories - Key offerings; 12.15 Siemens Healthineers AG; Siemens Healthineers AG - Overview; Siemens Healthineers AG - Business segments; Siemens Healthineers AG - Key news; Siemens Healthineers AG - Key offerings; Siemens Healthineers AG - Segment focus; 12.16 Zydus Lifesciences Ltd.; Zydus Lifesciences Ltd. - Overview; Zydus Lifesciences Ltd. - Business segments; Zydus Lifesciences Ltd. - Key news; Zydus Lifesciences Ltd. - Key offerings; Zydus Lifesciences Ltd. - Segment focus
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 13.3 Currency conversion rates for US$; Currency conversion rates for US$; 13.4 Research methodology; Research methodology; 13.5 Data procurement; Information sources; 13.6 Data validation; Data validation; 13.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 13.8 Data synthesis; Data synthesis; 13.9 360 degree market analysis; 360 degree market analysis; 13.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel; Exhibits6: Executive Summary - Chart on Market Segmentation by Application; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Company Market Positioning; Exhibits10: Parent Market; Exhibits11: Data Table on - Parent Market; Exhibits12: Market characteristics analysis; Exhibits13: Value Chain Analysis; Exhibits14: Offerings of companies included in the market definition; Exhibits15: Market segments; Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million); Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million); Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%); Exhibits20: Historic Market Size - Data Table on Global Non-Alcoholic Steatohepatitis (NASH) Market 2018 - 2022 ($ million); Exhibits21: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million); Exhibits22: Historic Market Size - Application Segment 2018 - 2022 ($ million); Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million); Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million); Exhibits25: Five forces analysis - Comparison between 2023 and 2028; Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits31: Chart on Market condition - Five forces 2023 and 2028; Exhibits32: Chart on Distribution Channel - Market share 2023-2028 (%); Exhibits33: Data Table on Distribution Channel - Market share 2023-2028 (%); Exhibits34: Chart on Comparison by Distribution Channel; Exhibits35: Data Table on Comparison by Distribution Channel; Exhibits36: Chart on Offline - Market size and forecast 2023-2028 ($ million); Exhibits37: Data Table on Offline - Market size and forecast 2023-2028 ($ million); Exhibits38: Chart on Offline - Year-over-year growth 2023-2028 (%); Exhibits39: Data Table on Offline - Year-over-year growth 2023-2028 (%); Exhibits40: Chart on Online - Market size and forecast 2023-2028 ($ million); Exhibits41: Data Table on Online - Market size and forecast 2023-2028 ($ million); Exhibits42: Chart on Online - Year-over-year growth 2023-2028 (%); Exhibits43: Data Table on Online - Year-over-year growth 2023-2028 (%); Exhibits44: Market opportunity by Distribution Channel ($ million); Exhibits45: Data Table on Market opportunity by Distribution Channel ($ million); Exhibits46: Chart on Application - Market share 2023-2028 (%); Exhibits47: Data Table on Application - Market share 2023-2028 (%); Exhibits48: Chart on Comparison by Application; Exhibits49: Data Table on Comparison by Application; Exhibits50: Chart on Diagnosis - Market size and forecast 2023-2028 ($ million); Exhibits51: Data Table on Diagnosis - Market size and forecast 2023-2028 ($ million); Exhibits52: Chart on Diagnosis - Year-over-year growth 2023-2028 (%); Exhibits53: Data Table on Diagnosis - Year-over-year growth 2023-2028 (%); Exhibits54: Chart on Treatment - Market size and forecast 2023-2028 ($ million); Exhibits55: Data Table on Treatment - Market size and forecast 2023-2028 ($ million); Exhibits56: Chart on Treatment - Year-over-year growth 2023-2028 (%); Exhibits57: Data Table on Treatment - Year-over-year growth 2023-2028 (%); Exhibits58: Market opportunity by Application ($ million); Exhibits59: Data Table on Market opportunity by Application ($ million); Exhibits60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits61: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibits62: Data Table on Market share By Geographical Landscape 2023-2028 (%); Exhibits63: Chart on Geographic comparison; Exhibits64: Data Table on Geographic comparison; Exhibits65: Chart on North America - Market size and forecast 2023-2028 ($ million); Exhibits66: Data Table on North America - Market size and forecast 2023-2028 ($ million); Exhibits67: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibits68: Data Table on North America - Year-over-year growth 2023-2028 (%); Exhibits69: Chart on Europe - Market size and forecast 2023-2028 ($ million); Exhibits70: Data Table on Europe - Market size and forecast 2023-2028 ($ million); Exhibits71: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibits72: Data Table on Europe - Year-over-year growth 2023-2028 (%); Exhibits73: Chart on Asia - Market size and forecast 2023-2028 ($ million); Exhibits74: Data Table on Asia - Market size and forecast 2023-2028 ($ million); Exhibits75: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibits76: Data Table on Asia - Year-over-year growth 2023-2028 (%); Exhibits77: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits78: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits79: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits80: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits81: Chart on US - Market size and forecast 2023-2028 ($ million); Exhibits82: Data Table on US - Market size and forecast 2023-2028 ($ million); Exhibits83: Chart on US - Year-over-year growth 2023-2028 (%); Exhibits84: Data Table on US - Year-over-year growth 2023-2028 (%); Exhibits85: Chart on Germany - Market size and forecast 2023-2028 ($ million); Exhibits86: Data Table on Germany - Market size and forecast 2023-2028 ($ million); Exhibits87: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibits88: Data Table on Germany - Year-over-year growth 2023-2028 (%); Exhibits89: Chart on Canada - Market size and forecast 2023-2028 ($ million); Exhibits90: Data Table on Canada - Market size and forecast 2023-2028 ($ million); Exhibits91: Chart on Canada - Year-over-year growth 2023-2028 (%); Exhibits92: Data Table on Canada - Year-over-year growth 2023-2028 (%); Exhibits93: Chart on China - Market size and forecast 2023-2028 ($ million); Exhibits94: Data Table on China - Market size and forecast 2023-2028 ($ million); Exhibits95: Chart on China - Year-over-year growth 2023-2028 (%); Exhibits96: Data Table on China - Year-over-year growth 2023-2028 (%); Exhibits97: Chart on UK - Market size and forecast 2023-2028 ($ million); Exhibits98: Data Table on UK - Market size and forecast 2023-2028 ($ million); Exhibits99: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibits100: Data Table on UK - Year-over-year growth 2023-2028 (%); Exhibits101: Market opportunity By Geographical Landscape ($ million); Exhibits102: Data Tables on Market opportunity By Geographical Landscape ($ million); Exhibits103: Impact of drivers and challenges in 2023 and 2028; Exhibits104: Overview on criticality of inputs and factors of differentiation; Exhibits105: Overview on factors of disruption; Exhibits106: Impact of key risks on business; Exhibits107: Companies covered; Exhibits108: Matrix on companies position and classification; Exhibits109: AstraZeneca Plc - Overview; Exhibits110: AstraZeneca Plc - Product / Service; Exhibits111: AstraZeneca Plc - Key news; Exhibits112: AstraZeneca Plc - Key offerings; Exhibits113: BioPredictive S.A.S - Overview; Exhibits114: BioPredictive S.A.S - Product / Service; Exhibits115: BioPredictive S.A.S - Key offerings; Exhibits116: Cirius Therapeutics - Overview; Exhibits117: Cirius Therapeutics - Product / Service; Exhibits118: Cirius Therapeutics - Key offerings; Exhibits119: Enzo Biochem Inc. - Overview; Exhibits120: Enzo Biochem Inc. - Product / Service; Exhibits121: Enzo Biochem Inc. - Key news; Exhibits122: Enzo Biochem Inc. - Key offerings; Exhibits123: GENFIT SA - Overview; Exhibits124: GENFIT SA - Product / Service; Exhibits125: GENFIT SA - Key offerings; Exhibits126: Gilead Sciences Inc. - Overview; Exhibits127: Gilead Sciences Inc. - Product / Service; Exhibits128: Gilead Sciences Inc. - Key news; Exhibits129: Gilead Sciences Inc. - Key offerings; Exhibits130: GlaxoSmithKline Plc - Overview; Exhibits131: GlaxoSmithKline Plc - Business segments; Exhibits132: GlaxoSmithKline Plc - Key news; Exhibits133: GlaxoSmithKline Plc - Key offerings; Exhibits134: GlaxoSmithKline Plc - Segment focus; Exhibits135: Intercept Pharmaceuticals Inc. - Overview; Exhibits136: Intercept Pharmaceuticals Inc. - Product / Service; Exhibits137: Intercept Pharmaceuticals Inc. - Key offerings; Exhibits138: Inventiva S.A. - Overview; Exhibits139: Inventiva S.A. - Product / Service; Exhibits140: Inventiva S.A. - Key offerings; Exhibits141: Madrigal Pharmaceuticals Inc. - Overview; Exhibits142: Madrigal Pharmaceuticals Inc. - Product / Service; Exhibits143: Madrigal Pharmaceuticals Inc. - Key offerings; Exhibits144: Novo Nordisk AS - Overview; Exhibits145: Novo Nordisk AS - Business segments; Exhibits146: Novo Nordisk AS - Key offerings; Exhibits147: Novo Nordisk AS - Segment focus; Exhibits148: Prometheus Laboratories - Overview; Exhibits149: Prometheus Laboratories - Product / Service; Exhibits150: Prometheus Laboratories - Key offerings; Exhibits151: Siemens Healthineers AG - Overview; Exhibits152: Siemens Healthineers AG - Business segments; Exhibits153: Siemens Healthineers AG - Key news; Exhibits154: Siemens Healthineers AG - Key offerings; Exhibits155: Siemens Healthineers AG - Segment focus; Exhibits156: Zydus Lifesciences Ltd. - Overview; Exhibits157: Zydus Lifesciences Ltd. - Business segments; Exhibits158: Zydus Lifesciences Ltd. - Key news; Exhibits159: Zydus Lifesciences Ltd. - Key offerings; Exhibits160: Zydus Lifesciences Ltd. - Segment focus; Exhibits161: Inclusions checklist; Exhibits162: Exclusions checklist; Exhibits163: Currency conversion rates for US$; Exhibits164: Research methodology; Exhibits165: Information sources; Exhibits166: Data validation; Exhibits167: Validation techniques employed for market sizing; Exhibits168: Data synthesis; Exhibits169: 360 degree market analysis; Exhibits170: List of abbreviations